ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 167 filers reported holding ALLAKOS INC in Q1 2021. The put-call ratio across all filers is 0.62 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,899 | -49.6% | 14,493 | -3.2% | 0.00% | – |
| Q2 2023 | $65,274 | -5.5% | 14,971 | -3.6% | 0.00% | – |
| Q1 2023 | $69,104 | -35.8% | 15,529 | +21.5% | 0.00% | -100.0% |
| Q4 2022 | $107,633 | +727.9% | 12,783 | +515.8% | 0.00% | – |
| Q3 2022 | $13,000 | +85.7% | 2,076 | -1.1% | 0.00% | – |
| Q2 2022 | $7,000 | -82.1% | 2,100 | -69.1% | 0.00% | – |
| Q1 2022 | $39,000 | -45.1% | 6,789 | -6.4% | 0.00% | – |
| Q4 2021 | $71,000 | -88.6% | 7,255 | +23.7% | 0.00% | -100.0% |
| Q3 2021 | $621,000 | +23.7% | 5,864 | -0.3% | 0.00% | 0.0% |
| Q2 2021 | $502,000 | -23.8% | 5,879 | +2.4% | 0.00% | -25.0% |
| Q1 2021 | $659,000 | +76.7% | 5,744 | +115.4% | 0.00% | +100.0% |
| Q4 2020 | $373,000 | +71.9% | 2,667 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $217,000 | +49.7% | 2,667 | +32.4% | 0.00% | +100.0% |
| Q2 2020 | $145,000 | +126.6% | 2,015 | +39.8% | 0.00% | 0.0% |
| Q1 2020 | $64,000 | -53.3% | 1,441 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $137,000 | +21.2% | 1,441 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $113,000 | – | 1,441 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 270,965 | $12,055,000 | 6.94% |
| NEA Management Company, LLC | 2,268,188 | $100,912,000 | 5.27% |
| Fairmount Funds Management LLC | 178,662 | $7,949,000 | 4.82% |
| Redmile Group, LLC | 2,976,928 | $132,444,000 | 3.71% |
| Boxer Capital, LLC | 675,000 | $30,031,000 | 2.05% |
| Rock Springs Capital Management LP | 235,000 | $10,455,000 | 0.43% |
| Cormorant Asset Management, LP | 200,000 | $8,898,000 | 0.41% |
| RAMIUS ADVISORS LLC | 31,155 | $1,386,000 | 0.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $692,000 | 0.32% |
| Handelsinvest Investeringsforvaltning | 20,000 | $890,000 | 0.24% |